SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,291 | -0.6% | 2,876 | +8.3% | 0.00% | 0.0% |
| Q2 2023 | $79,809 | -21.8% | 2,655 | -5.8% | 0.00% | -20.0% |
| Q1 2023 | $102,096 | -6.7% | 2,818 | -8.1% | 0.01% | 0.0% |
| Q4 2022 | $109,400 | +10.8% | 3,067 | +5.1% | 0.01% | 0.0% |
| Q3 2022 | $98,774 | +17.0% | 2,918 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $84,389 | -10.5% | 2,918 | 0.0% | 0.00% | +33.3% |
| Q1 2022 | $94,310 | -75.6% | 2,918 | -78.0% | 0.00% | -40.0% |
| Q4 2021 | $386,632 | +9.3% | 13,259 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $353,618 | -27.4% | 13,259 | -16.1% | 0.01% | -28.6% |
| Q2 2021 | $486,851 | +22.1% | 15,812 | +3.8% | 0.01% | +16.7% |
| Q1 2021 | $398,643 | -0.4% | 15,227 | -4.3% | 0.01% | 0.0% |
| Q4 2020 | $400,145 | +20.7% | 15,904 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $331,439 | -12.3% | 15,904 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $377,720 | +32.0% | 15,904 | 0.0% | 0.01% | +16.7% |
| Q1 2020 | $286,113 | -24.2% | 15,904 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $377,243 | -13.7% | 15,904 | 0.0% | 0.01% | -14.3% |
| Q3 2019 | $437,042 | -17.0% | 15,904 | 0.0% | 0.01% | -22.2% |
| Q2 2019 | $526,263 | -5.6% | 15,904 | 0.0% | 0.01% | -10.0% |
| Q1 2019 | $557,276 | +5.5% | 15,904 | 0.0% | 0.01% | -9.1% |
| Q4 2018 | $528,331 | -34.0% | 15,904 | 0.0% | 0.01% | -21.4% |
| Q3 2018 | $800,766 | -99.9% | 15,904 | 0.0% | 0.01% | -6.7% |
| Q2 2018 | $951,854,000 | +32.2% | 15,904 | +1.2% | 0.02% | +50.0% |
| Q1 2018 | $719,839,000 | +114890.3% | 15,717 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $626,000 | -50.0% | 15,717 | -49.8% | 0.01% | 0.0% |
| Q3 2017 | $1,252,000 | -13.8% | 31,298 | -7.1% | 0.01% | -20.0% |
| Q2 2017 | $1,452,000 | +37.8% | 33,686 | 0.0% | 0.01% | +42.9% |
| Q1 2017 | $1,054,000 | +19.9% | 33,686 | -3.2% | 0.01% | +16.7% |
| Q4 2016 | $879,000 | +2.1% | 34,803 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $861,000 | +21.4% | 34,803 | 0.0% | 0.01% | +20.0% |
| Q2 2016 | $709,000 | +54.1% | 34,803 | +15.5% | 0.01% | +25.0% |
| Q1 2016 | $460,000 | +48.9% | 30,133 | +31.2% | 0.00% | +100.0% |
| Q4 2015 | $309,000 | -4.0% | 22,971 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $322,000 | -24.9% | 22,971 | -9.1% | 0.00% | -33.3% |
| Q2 2015 | $429,000 | +49.5% | 25,274 | +6.6% | 0.00% | +50.0% |
| Q1 2015 | $287,000 | +45.7% | 23,720 | 0.0% | 0.00% | +100.0% |
| Q4 2014 | $197,000 | -4.4% | 23,720 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $206,000 | -20.8% | 23,720 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $260,000 | – | 23,720 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |